4//SEC Filing
HARDY REGINALD L 4
Accession 0001062993-20-004554
CIK 0000819050other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 5:06 PM ET
Size
10.6 KB
Accession
0001062993-20-004554
Insider Transaction Report
Form 4
HARDY REGINALD L
DirectorChairman of the Board
Transactions
- Award
Stock Option (right to buy)
2020-09-15+60,000→ 60,000 totalExercise: $0.80Exp: 2030-09-15→ Common Stock (60,000 underlying) - Award
Common Stock
2020-09-15$0.81/sh+15,226$12,333→ 205,849 total
Holdings
- 21,826(indirect: By Spouse)
Common Stock
- 9,261(indirect: By Spouse)
Common Stock
- 266,447(indirect: By Self as General Partner)
Common Stock
- 17,260(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]On September 15, 2020, the reporting person was granted 15,226 restricted stock units ("RSUs") in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2020 and will be settled in the form of one share of common stock for each RSU.
- [F2]The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years.
Issuer
Brickell Biotech, Inc.
CIK 0000819050
Entity typeother
Related Parties
1- filerCIK 0001008105
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 5:06 PM ET
- Size
- 10.6 KB